Brief: Disc Medicine Presents Positive Data From SAD Cohorts Of A Phase 1B Trial In Patients With Chronic Kidney Disease & Anemia At ASN Kidney Week
25/10/2024 19:07
Oct 25 (Reuters) - Disc Medicine Inc IRON.O :
* DISC MEDICINE PRESENTS POSITIVE DATA FROM SAD COHORTS OF A
PHASE
1B TRIAL IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) AND
ANEMIA AT THE 2024 AMERICAN SOCIETY OF NEPHROLOGY (ASN) KIDNEY
WEEK
* DISC MEDICINE INC - DISC-0974 SHOWS ACCEPTABLE SAFETY AND
TOLERABILITY AT ALL DOSE LEVELS
Source text for Eikon: ID:nGNX2X5w22
Further company coverage: IRON.O
((Reuters.Briefs@thomsonreuters.com;))